Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium

scientific article published on 01 December 2019

Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1167/IOVS.19-27872
P698PubMed publication ID31800960

P2093author name stringKwang Pyo Kim
Hyung Keun Lee
Myoung Joon Kim
Chul Young Choi
Kyoung Yul Seo
Hye Min Kim
Hyun Seung Kim
Areum Yeo
Yong Woo Ji
Jong Suk Song
Jae Won Oh
Sun Young Ryu
P2860cites workComparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trialQ92819625
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue15
P921main subjectcyclosporineQ367700
eye diseaseQ3041498
P304page(s)5035-5044
P577publication date2019-12-01
P1433published inInvestigative Ophthalmology Visual ScienceQ6060707
P1476titleChanges in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium
P478volume60

Search more.